ES3035188T3 - Anti-viral compositions - Google Patents

Anti-viral compositions

Info

Publication number
ES3035188T3
ES3035188T3 ES19808612T ES19808612T ES3035188T3 ES 3035188 T3 ES3035188 T3 ES 3035188T3 ES 19808612 T ES19808612 T ES 19808612T ES 19808612 T ES19808612 T ES 19808612T ES 3035188 T3 ES3035188 T3 ES 3035188T3
Authority
ES
Spain
Prior art keywords
lip balm
oil
composition
solid
acyclovir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19808612T
Other languages
English (en)
Spanish (es)
Inventor
Daniel Calladine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Calladine Pharmaceuticals Ltd
Original Assignee
Calladine Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calladine Pharmaceuticals Ltd filed Critical Calladine Pharmaceuticals Ltd
Application granted granted Critical
Publication of ES3035188T3 publication Critical patent/ES3035188T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES19808612T 2018-11-29 2019-11-28 Anti-viral compositions Active ES3035188T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1819418.3A GB201819418D0 (en) 2018-11-29 2018-11-29 Anti-viral compositions
PCT/EP2019/082850 WO2020109442A1 (en) 2018-11-29 2019-11-28 Anti-viral compositions

Publications (1)

Publication Number Publication Date
ES3035188T3 true ES3035188T3 (en) 2025-08-29

Family

ID=65024906

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19808612T Active ES3035188T3 (en) 2018-11-29 2019-11-28 Anti-viral compositions

Country Status (8)

Country Link
US (1) US12295956B2 (https=)
EP (1) EP3886861B1 (https=)
JP (1) JP2022509240A (https=)
AU (1) AU2019389762B2 (https=)
CA (1) CA3121051A1 (https=)
ES (1) ES3035188T3 (https=)
GB (1) GB201819418D0 (https=)
WO (1) WO2020109442A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240350570A1 (en) * 2023-04-19 2024-10-24 Daniel Tyler WHITING Topical skin care preparation comprising ephedra viridis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
LU85083A1 (fr) * 1983-11-09 1985-07-17 Oreal Composition cosmetique ou pharmaceutique sous forme d'un baton ou stick constitue de deux phases grasses concentriques,son procede de preparation et etui en permettant sa conservation et sa distribution
DK169121B1 (da) 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
RU2093140C1 (ru) 1995-03-09 1997-10-20 Товарищество с ограниченной ответственностью "Снежный Барс" Лечебно-профилактическая помада и способ ее приготовления
AU2036297A (en) 1996-03-20 1997-10-10 Glaxo Group Limited Topical formulations of aciclovir
IT1287114B1 (it) * 1996-10-31 1998-08-04 Recordati Chem Pharm Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
FR2773032B1 (fr) 1997-12-22 2001-12-21 Nortel Matra Cellular Modulation d'un signal numerique a spectre etroit et a enveloppe sensiblement constante
ITMI981528A1 (it) 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
JP2003128521A (ja) * 2001-10-16 2003-05-08 Rohto Pharmaceut Co Ltd 外用製剤
RU2282473C2 (ru) * 2002-02-04 2006-08-27 Закрытое акционерное общество "Эвалар" Лечебно-профилактическая помада с противовирусной активностью и способ ее приготовления
US8697712B2 (en) 2004-04-05 2014-04-15 Laboratorios Liomont, S.A. De C.V. Presentation of an antiviral pharmaceutical composition
US20080031979A1 (en) * 2006-08-04 2008-02-07 Claude Saliou Use of extracts for the treatment of viral disorders
US7695727B2 (en) * 2006-10-11 2010-04-13 Wyeth Llc Botanical butter stick lip balm
US8333955B2 (en) 2007-03-19 2012-12-18 Elc Management Llc High shine, stick-shaped cosmetic products
EP1977729B1 (en) * 2007-04-05 2010-03-03 Eckart GmbH Cosmetic compositions containing pearlescent pigments
CN100562631C (zh) 2007-04-05 2009-11-25 崔文瀛 球网壳组合结构
US20100135945A1 (en) * 2008-12-02 2010-06-03 Kreations By Kristin, Llc Gymnema-containing lip balm compositions and associated methods
WO2013077881A1 (en) 2011-11-23 2013-05-30 3B Pharmaceuticals, Inc. Antiviral formulations
US8722106B2 (en) * 2011-12-02 2014-05-13 The MotherVine Nutraceuticals Co. LLC Lip balm composition
BE1022817B1 (nl) * 2015-08-25 2016-09-13 Stasisport Pharma Nv Antivirale samenstelling en lippenstift omvattende genoemde samenstelling

Also Published As

Publication number Publication date
CA3121051A1 (en) 2020-06-04
EP3886861A1 (en) 2021-10-06
EP3886861B1 (en) 2025-05-07
US12295956B2 (en) 2025-05-13
US20220016124A1 (en) 2022-01-20
AU2019389762B2 (en) 2025-07-31
GB201819418D0 (en) 2019-01-16
EP3886861C0 (en) 2025-05-07
WO2020109442A1 (en) 2020-06-04
AU2019389762A1 (en) 2021-07-01
JP2022509240A (ja) 2022-01-20

Similar Documents

Publication Publication Date Title
ES2352222T3 (es) Preparación farmacéutica y/o cosmética que contiene un organoxilosano y un fosfolípido.
Sahu et al. Skin cream as topical drug delivery system: a review
US8883225B2 (en) Water-soluble pharmaceutical compositions of hops resins
US20130059019A1 (en) Methods and compositions for treating inflammation of skin
TW200836769A (en) Topical pharmaceutical formulation
JP2003528821A (ja) 局所適用のための薬学的および化粧用の担体または組成物
ES2301200T3 (es) Preparaciones externas que contienen extracto de berro.
US10736836B2 (en) Method of treating external tissues with waxes
ES2360469T3 (es) Composición farmacéutica que comprende un ungüento oleaginoso y dos principios activos en forma solubilizada.
US20220110993A1 (en) Compositions for treatment of jaw pain, temporomandibular joint and muscle disorder and bruxism
ES3035188T3 (en) Anti-viral compositions
ES2536713T3 (es) Composiciones para la piel lipófilas de rápida absorción y usos de las mismas
ES2717625T3 (es) Composición para tratamiento preventivo del herpes labial
WO2011057363A1 (en) Disposable device and uses thereof for skin and mucosal applications
JP2022509240A5 (https=)
JP6484251B2 (ja) ミツバチ生成物を含む組成物
CN102711751A (zh) 药物组合物
JP2023183349A (ja) 固形外用組成物
JP2003055185A5 (https=)
WO2017105207A1 (es) Composicion farmaceutica para tratamiento de heridas, quemaduras y ulceras cutaneas
Sahu et al. Journal of Pharmaceutical and Biological Sciences